We are monitoring the impact of COVID-19 on North America NGS Market Get in touch with us for detailed analysis Know More
Share on

North America Next-Generation Sequencing Market Analysis Report – Segmented By Product, Technology, Application and Country (the U.S., Canada, Mexico & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 93
Pages: 145

North American NGS Market Size (2022 to 2027)

The North American Next-generation sequencing market was worth USD 1.53 billion in 2022 and is estimated to reach USD 3.33 billion by 2027, growing at a CAGR of 16.81% during the forecast period.

The significant factors propelling the growth of the North American NGS market are the increasing incidence of cancer, the increasing applications of NGS in precision medicine, and biomarker discovery. In addition, the rise in the adoption rate of NGS platforms for analysis and diagnostics of rare diseases and for identifying therapeutic targets, the emergence of rapid and advanced sequencing technologies, reduced costs of sequencing, growing demand for NGS methodologies in genomics research, and in clinical diagnosis are further driving the market growth.

Furthermore, growth in investments in R&D activities due to the high occurrence of cancer and infectious diseases and the development of Next-Generation Sequencing Bioinformatics equipment, and the presence of a significant player in the region drives the market growth. On the other hand, usage of NGS in biomarker detection and precision medicine is likely to positively impact the growth of North America's next-generation sequencing market in the coming years.

The significant challenges restricting the growth of the North American NGS market are expensive technologies that are not affordable due to budget limitations in developing economies and risks involved with genetic data.

This research report on the North American NGS market has been segmented and sub-segmented into the following categories:

By Product: 

  • Software
  • Services

By Technology: 

  • Targeted Re-Sequencing
  • Whole Genome Sequencing
  • De Novo Sequencing
  • Exome Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq

By Application: 

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture
  • Animals Research

By Country: 

  • The United States
  • Canada
  • Mexico
  • Rest of North America

Regionally, the U.S. NGS Market dominates the NGS market in North America and is expected to maintain the trend during the forecast period due to rapid developments in healthcare, particularly in the biotechnology field. Canada is displaying significant growth in recent years. It is likely to grow consistently during the forecast period owing to the research advancements and rising adoption of NGS products in hospitals and clinics. 

The U.S. NGS market is estimated to register a promising CAGR during the forecast period and contains all sequencing services directed with next-generation or third-generation platforms that use newer technology than old capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation, and NGS-based sequencing run with primary data output. The increasing number of Next Generation Sequencing new research activities in Canadian universities is leading to the growth of the Next Generation Sequencing data analysis market in the U.S.

The Canadian NGS market is projected to grow at a healthy CAGR from 2022 to 2027.

KEY MARKET PLAYERS:

Companies playing a leading role in the North American NGS Market profiled in this report are Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc., Partek Inc., Genomatix Software GmbH, Perkin Elmer Inc., GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., DNASTAR Inc., Knome Inc., and Qiagen N.V.

  1. Introduction

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

  1. Research Methodology

                2.1 Introduction               

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

  1. Overview

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

  1. Market Segmentation

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology           

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

  1. Geographical Analysis

                6.1 Introduction               

                6.2 United States            

                6.3 Canada         

  1. Strategic Analysis

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

  1. Market Leaders' Analysis

                8.1 Macrogen Inc.           

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Thermo Fischer Scientific      

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences   

                8.5 Life Technologies Corp.         

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer Inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.       

                8.12 CLC Bio (Qiagen)    

                8.13 Pacific Biosciences 

  1. Competitive Landscape

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

  1. Expert Opinions

                10.1 Market Outlook     

                10.2 Investment Opportunities 

     Appendix                          

  1. List of Tables
  2. List of Figures
  1. North America NGS Market By Region, From 2022 - 2027 (USD Billion)
  2. North America NGS Market By Product, From 2022 - 2027 (USD Billion)
  3. North America Software Market By Region, From 2022 - 2027 (USD Billion)
  4. North America Services Market By Region, From 2022 - 2027 (USD Billion)
  5. North America NGS Market By Technology, From 2022 - 2027 (USD Billion)
  6. North America Whole Targeted Re-Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  7. North America Genome Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  8. North America De Novo Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  9. North America Exome Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  10. North America RNA-Seq Market By Region, From 2022 - 2027 (USD Billion)
  11. North America ChIP-Seq Market By Region, From 2022 - 2027 (USD Billion)
  12. North America Methyl-Seq Market By Region, From 2022 - 2027 (USD Billion)
  13. North America NGS Market By Application, From 2022 - 2027 (USD Billion)
  14. North America Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  15. North America Drug Discovery Market By Region, From 2022 - 2027 (USD Billion)
  16. North America Biomarker Discovery Market By Region, From 2022 - 2027 (USD Billion)
  17. North America Personalized Medicine Market By Region, From 2022 - 2027 (USD Billion)
  18. North America Agriculture and Animals Research Market By Region, From 2022 - 2027 (USD Billion)
  19. United States NGS Market By Product, From 2022 - 2027 (USD Billion)
  20. United States NGS Market By Technology, From 2022 - 2027 (USD Billion)
  21. United States NGS Market By Application, From 2022 - 2027 (USD Billion)
  22. Canada NGS Market By Product, From 2022 - 2027 (USD Billion)
  23. Canada NGS Market By Technology, From 2022 - 2027 (USD Billion)
  24. Canada NGS Market By Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample